Variants in blood pressure genes and the risk of renal cell carcinoma

Carcinogenesis

Volumn 31, Issue 4, 2010, Pages 614-620

  Andreotti, Gabriella ^a   Boffetta, Paolo ^b   Rosenberg, Philip S ^a   Berndt, Sonja I ^a   Karami, Sara ^a   Menashe, Idan ^a   Yeager, Meredith ^a   Chanock, Stephen J ^a   Zaridze, David ^c   Matteev, Vsevolod ^c   Janout, Vladimir ^d   Kollarova, Hellena ^d   Bencko, Vladimir ^e   Navratilova, Marie ^f   Szeszenia Dabrowska, Neonilia ^g   Mates, Dana ^h   Rothman, Nathaniel ^a   Brennan, Paul ^b   Chow, Wong Ho ^a   Moore, Lee E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d PALACKÝ UNIVERSITY   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Masaryk Memorial Cancer Institute   (Russian Federation)

^g NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^h NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; HYPERTENSION; INTRON; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CLINICAL TRIAL; GENE LINKAGE DISEQUILIBRIUM; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR;

ADULT; AGED; ANGIOTENSINOGEN; BODY MASS INDEX; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; KIDNEY NEOPLASMS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77950914224     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp321     Document Type: Article

References (30)

1. McLaughlin, J.K. et al. International renal-cell cancer study VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int. J. Cancer, 63, 216-221.
2. Yuan, J.M. et al. (1998) Hypertension, obesity and their medications in relation to renal cell carcinoma. Br. J. Cancer, 77, 1508-1513.
3. Chow, W.H. et al. (2000) Obesity, hypertension, and the risk of kidney cancer in men. N. Engl. J. Med., 343, 1305-1311.
4. Chow, W.H. et al. (2006) Epidemiology of renal cell carcinoma. In Vogelzang, N., Scardino, P., Shipley, W., Debruyne, F. and Linehan, W. (eds.) Comprehensive Textbook of Genitourinary Oncology, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp. 669-679.
5. McLaughlin, J.K. et al. 2006 Cancer Epidemiology and Prevention (Edition III). Oxford University Press, pp.787-800.
6. Schlehofer, B. et al. (1996) International renal-cell-cancer study. VI. The role of medical and family history. Int. J. Cancer, 66, 723-726.
7. Lindblad, P. et al. (1999) The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia, 42, 107-112.
8. Gago-Domiguez, M. et al. (2002) Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control, 13, 287-293.
9. Moore, L.E. et al. (2009) Apolipoprotein E/CI locus variants modify renal cell carcinoma risk. Cancer Res., 69, 8001-8008.
10. Parkin, C.M. et al. Cancer Incidence in Rive Continents, Volume VIII. IARC Scientific Publications NO 155. International Agency for Research on Cancer, Lyon.
11. Zbar, B. (2000) Inherited epithelial tumors of the kidney: old and new diseases. Semin. Cancer Biol., 10, 313-318.
12. Gago-Dominguez, M. et al. (2001) Family history and risk of renal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 10, 1001-1004.
13. Moore, L.E. et al. (2008) Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int. J. Cancer, 122, 1710-1715.
14. Moore, L.E. et al. (2007) Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis, 28, 1960-1964.
15. Brennan, P. et al. (2008) Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br. J. Cancer, 99, 1912-1915.
16. Carlson, C.S. et al. (2004) Selecting a maximally informative set of singlenucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet., 74, 106-120.
17. Packer, B.R. et al. (2006) SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res., 34, D617-D621.
18. Chen, B.E. et al. (2006) Resampling-based multiple hypothesis testing procedures for genetic case-control association studies. Genet. Epidemiol., 30, 495-507.
19. Benjamini, Y. et al. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Methodol., 57, 289-300.
20. Barrett, J.C. et al. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
21. Excoffier, L. et al. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
22. Schaid, D.J. et al. (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet., 70, 425-434.
23. Corvol, P. et al. (1999) Seven lessons from two candidate genes in human essential hypertension: angiotensinogen and epithelial sodium channel. Hypertension, 33, 1324-1331.
24. Yanai, K. et al. (1996) A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J. Biol. Chem., 271, 15981-15986.
25. Sarzani, R. et al. (2009) Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue. J. Hum. Hypertens, 1-7.
26. González-Zuloeta Ladd, A.M. et al. (2007) Differential roles of Angiotensinogen and Angiotensin Receptor type 1 polymorphisms in breast cancer risk. Breast Cancer Res. Treat., 101, 299-304.
27. Vašků, A. et al. (2008) Obesity-related genes variability in Czech patients with sporadic colorectal cancer: preliminary results. Int. J. Colorectal. Dis., 24, 289-294.
28. Sugimoto, M. et al. (2007) Role of angiotensinogen gene polymorphism on Helicobacter pylori infection-related gastric cancer risk in Japanese. Carcinogenesis, 28, 2036-2040.
29. Staessen, J.A. et al. (1997) Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J. Cardiovasc. Risk, 4, 401-422.
30. Wacholder, S. et al. (2002) Counterpoint: bias from population stratfication is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol. Biomarkers Prev., 11, 513-520.